journal article·2026-08Open access

Effects of twisting and composition on the degradation of electrospun polycaprolactone/poly(lactic-co-glycolic acid) blend sutures

Anderson Eugênio Corrêa, Cleverson Fernando Garcia, Mayra Aparecida Nascimento, Isabela Louise Pereira Lopes, Érika Costa de Alvarenga, Priscila Pereira Silva-Caldeira

Abstract

Electrospun biodegradable sutures enable tailoring of mechanical performance and degradation behavior through polymer composition and post-processing. However, quantitative design guidelines linking blend composition, twisting, degradation kinetics, and mechanical properties remain limited. This study establishes such relationships in continuous multifilament sutures based on polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA, D, l -lactide:glycolide, 50:50 M ratio) blends. Sutures were fabricated using a disk-shaped electrospinning collector coupled to an automated twisting system. The effects of degradation time and PLGA content (0–40 wt% in PCL/PLGA blends) on mass loss and mechanical properties were analyzed and response surface methodology (RSM) was employed to identify correlations between these parameters. Samples were subjected to in vitro hydrolytic degradation in PBS (pH 7.4, 37 °C) for up to 60 days and comprehensively characterized throughout the degradation period. Twisting enabled the formation of cohesive multifilament structures, influencing fiber packing, mechanical integrity, and degradation behavior. Increasing PLGA content significantly accelerated hydrolytic degradation while simultaneously enhancing tensile strength and stiffness, evidencing a composition-dependent between mechanical support and resorption rate. In addition, the sutures exhibited cell viability above 70%. Notably, the PCL/PLGA (60/40) formulation exhibited favorable environment for cell adhesion and proliferation and the highest mass loss after 60 days while maintaining superior mechanical performance compared to neat PCL. Overall, this study provides composition- and processing-dependent design guidelines for electrospun PCL/PLGA sutures, demonstrating that twisting is a critical parameter for tailoring structural and functional performance toward specific clinical demands.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: biodegradable polymer synthesis and properties · Electrospun Nanofibers in Biomedical Applications · Surgical Sutures and Adhesives

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Suture materials: conventional and stimulatory-responsive absorbable polymers with biomimetic function10.3390/biomimetics10090590 ↗
2. Individualized wound closure-mechanical properties of suture materials10.3390/jpm12071041 ↗
3. A regeneration process-matching scaffold with appropriate dynamic mechanical properties and spatial adaptability for ligament reconstruction
4. A review on melt-spun biodegradable fibers10.3390/su151914474 ↗
5. Biodegradable suture threads as controlled drug delivery systems10.1080/14328917.2019.1619982 ↗
6. Electrospun medical sutures for wound healing: a review10.3390/polym14091637 ↗
7. Next generation pressure spinning technology for surgical suture manufacturing10.1016/j.matdes.2025.114326 ↗
8. Electrospun janus beads-on-a-string structures for different types of controlled release profiles of double drugs10.3390/biom11050635 ↗
9. Electroactive electrospun nanofibers for tissue engineering10.1016/j.nantod.2021.101196 ↗
10. Engineering and polymeric composition of drug-eluting suture: a review10.1002/jbm.a.37194 ↗
11. Biodegradable polyesters: approaches to increase degradation rates for biomedical applications10.1021/acsmacrolett.5c00417 ↗
12. Degradation of Poly(ε-caprolactone) resorbable multifilament yarn under physiological conditions10.3390/polym15183819 ↗
13. Role of the lactide:glycolide ratio in PLGA nanoparticle stability and release under lysosomal conditions for enzyme replacement therapy of lysosomal storage disorders10.3390/jfb14090440 ↗
14. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres10.1016/j.jconrel.2005.05.024 ↗
15. Relationships between mechanical properties and drug release from electrospun fibers of PCL and PLGA blends10.1016/j.jmbbm.2016.09.004 ↗
16. New insights into the PLGA and PCL blending: Physico-mechanical properties and cell response10.1088/2053-1591/ab2823 ↗
17. The development of 5-fluorouracil biodegradable implants: a comparative study of PCL/PLGA blends
18. Drug eluting sutures: a recent update10.7324/JAPS.2019.90716 ↗
19. Effect of blending ratio on morphological, chemical, and thermal characteristics of PLA/PCL and PLLA/PCL electrospun fibrous webs10.1080/00914037.2022.2090356 ↗
20. Electrospun PCL/Gelatin composite fibrous scaffolds: mechanical properties and cellular responses10.1080/09205063.2016.1160560 ↗
21. Engineering electrospun PAN/PCL blend for high-performance and eco-friendly particulate matter filtration10.1016/j.reactfunctpolym.2024.106026 ↗
22. Development of braided drug-loaded nanofiber sutures10.1088/0957-4484/21/31/315104 ↗
23. Integrating substrateless electrospinning with textile technology for creating biodegradable three-dimensional structures10.1021/acs.nanolett.5b01815 ↗
24. Investigation of nanoyarn preparation by modified electrospinning setup10.1002/app.44813 ↗
25. Tailoring polycaprolactone/silk electrospun nanofiber yarns by varying compositional and processing parameters10.1007/s00289-023-04735-3 ↗
26. Strip twisted electrospun nanofiber yarns: structural effects on tensile properties10.1557/jmr.2011.295 ↗
27. Fabrication of aligned and molecularly oriented electrospun polyacrylonitrile nanofibers and the mechanical behavior of their twisted yarns10.1016/j.polymer.2004.04.001 ↗
28. The power of fiber twist10.1021/acs.accounts.1c00112 ↗
29. Mechanical properties and degradability of electrospun PCL/PLGA blended scaffolds as vascular grafts10.1007/s12209-018-0152-8 ↗
30. Twisting electrospun nanofiber fine strips into functional sutures for sustained co-delivery of gentamicin and silver10.1016/j.nano.2017.01.016 ↗
31. Estimation of digital porosity of electrospun veils by image analysis10.3390/polym16020300 ↗
32. Advanced rheological, dynamic mechanical and thermal characterization of phase-separation behavior of PLA/PCL blends
33. Modeling electrospun PLGA nanofibers' diameter using response surface methodology and artificial neural networks10.1177/15280837221142641 ↗
34. Degradation behaviors of polylactic acid, polyglycolic acid, and their copolymer films in simulated marine environments10.3390/polym16131765 ↗
35. Factors controlling degradation of biologically relevant synthetic polymers in solution and solid state10.1021/acsabm.2c00694 ↗
36. Effect of mechanical loading on PLGA biodegradation10.1016/j.polymdegradstab.2025.111485 ↗
37. Polyphenolic compounds affect the long-term degradation behaviour of polymer and composite materials based on PCL, PLGA, and bioactive glass
38. Molecular and macroscopic considerations for degradable aliphatic polyester biomaterial design10.1021/acs.biomac.5c00765 ↗
39. The contemporary role of ε-caprolactone chemistry to create advanced polymer architectures10.1016/j.polymer.2013.04.045 ↗
40. Electrospun PCL/PVP nanofibers embedded with magnetic nanoparticles: correlating porosity, structure and magneto-thermo-mechanical properties10.1016/j.jmmm.2026.173941 ↗
41. Influence of thickness on the properties of electrospun PCL/gelatin nanofiber scaffolds10.1007/s00289-024-05159-3 ↗
42. Improved porosity of electrospun poly (Lactic-Co-Glycolic) scaffolds by sacrificial microparticles enhances cellular infiltration compared to sacrificial microfiber10.1177/08853282221075890 ↗
43. Investigation of cell adhesion and cell viability of the endothelial and fibroblast cells on electrospun PCL, PLGA and coaxial scaffolds for production of tissue engineered blood vessel10.3390/jfb13040282 ↗
44. Rayleigh-Instability-driven morphology transformation by thermally annealing electrospun polymer fibers on substrates10.1021/ma300964y ↗
45. Unique fiber morphologies from emulsion electrospinning—A case study of Poly(ε-caprolactone) and its applications10.3390/colloids7010019 ↗
46. Rayleigh instability-driven coaxial spinning of knotted cell-laden alginate fibers as artificial lymph vessels10.1021/acsami.1c00798 ↗
47. Biomimicking dual drug eluting twisted electrospun nanofiber yarns for post-operative wound healing10.1088/1748-605X/acc4a1 ↗
48. Optimization of electrospinning process & parameters for producing defect-free chitosan/polyethylene oxide nanofibers for bone tissue engineering10.1080/09205063.2020.1718824 ↗
49. Defect minimization and feature control in electrospinning through design of experiments10.1002/app.44740 ↗
50. Electrospinning of PLA with DMF: effect of polymer concentration on the bead diameter of the electrospun fibre10.1088/1757-899X/778/1/012087 ↗
51. Surface coating prolongs the degradation and maintains the mechanical strength of surgical suture in vivo10.1016/j.colsurfb.2021.112214 ↗
52. How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release10.1080/02652048.2020.1729885 ↗
53. Imaging the porous structure in the core of degrading PLGA microparticles: the effect of molecular weight10.1016/j.jconrel.2018.07.044 ↗
54. Bioactive nano yarns as surgical sutures for wound healing10.1016/j.msec.2021.112334 ↗
55. Poly-ε-Caprolactone/Propolis electrospun yarns as suture10.1007/s12221-023-00257-x ↗
56. Bioresorbable films of polycaprolactone blended with poly(lactic acid) or poly(lactic-co-glycolic acid)10.1016/j.ijbiomac.2023.126654 ↗
57. Investigating novel syntheses of a series of unique hybrid PLGA-chitosan polymers for potential therapeutic delivery applications10.3390/polym12040823 ↗
58. Development and characterization of PLGA nanoparticles containing antibiotics10.1007/s11051-018-4387-z ↗
59. Preparation and characterization of PLA/PCL/HA composite scaffolds using indirect 3D printing for bone tissue engineering10.1016/j.msec.2019.109960 ↗
60. Biodegradation of polycaprolactone (PCL) with different molecular weights by Candida Antarctica lipase10.1007/s10924-020-01826-4 ↗
61. Drug release behavior of electrospun twisted yarns as implantable medical devices10.1088/1758-5090/8/3/035019 ↗
62. A review on the thermomechanical properties and biodegradation behaviour of polyesters10.1016/j.eurpolymj.2019.109296 ↗
63. Degradation and characterisation of electrospun polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA) scaffolds for vascular tissue engineering10.3390/ma14174773 ↗
64. Polycaprolactone as biomaterial for bone scaffolds: review of literature10.1016/j.jobcr.2019.10.003 ↗
65. Cellulose-based suture: state of art, challenge, and future outlook
66. Cellulose formate‐based surgical sutures with tunable absorbability and enhanced biocompatibility10.1002/smll.202513264 ↗
67. Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment10.1016/j.progpolymsci.2019.05.004 ↗
68. The return of a forgotten polymer - polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
69. Electrospun PLGA/PCL nanofiber film loaded with LPA promotes full-layer wound healing by regulating the keratinocyte pyroptosis10.1021/acsami.4c22495 ↗
70. 3D printed-electrospun PCL/hydroxyapatite/MWCNTs scaffolds for the repair of subchondral bone10.1093/rb/rbac104 ↗
71. A review on the recent applications of synthetic biopolymers in 3D printing for biomedical applications10.1007/s10856-023-06765-9 ↗
72. Puppi
73. The effect of polymer blends on the in vitro release/degradation and pharmacokinetics of moxidectin-loaded PLGA microspheres